Search Results 2011-2020 of 16062 for Epilepsy (Partial Onset)

  1. Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells - Mayo Clinic

    Seizures or history of significant neurological injury;; Multi-system organ failure including acute or chronic renal failure. Participating Mayo Clinic ...

  2. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

    Ixazomib citrate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, ...

  3. Pegfilgrastim (subcutaneous route) - Mayo Clinic

    Pegfilgrastim injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  4. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

    Patients will undergo restaging scans every 3 cycles. Subjects will be monitored for adverse events from the beginning of the study drug to 28 days after the ...

  5. Central Sleep Apnea Clinical Trials - Mayo Clinic Research

    A second part of this study will involve using a Fitbit consumer wearable device to obtain sleep and activity data on participants for 2 months in duration. .

  6. Alectinib (oral route) - Mayo Clinic

    Your doctor will perform a test to check for the ALK gene before you use this medicine. Alectinib belongs to the group of medicines called antineoplastics ( ...

  7. Sharing Mayo Clinic - 2013 Archives

    My name is Jill Staloch, and I had my first seizure when I was a freshman in college. Epilepsy never impacted my life, besides having[...].

  8. Funding - Research - Mayo Clinic Research

    Funding Source, Duration. Keith D. Robertson, Ph.D., principal investigator, Epigenetic heterogeneity as a driver of liver disease and cancer (R01 AA27179) ...

  9. Perampanel Transcranial Magnetic Stimulation (TMS) in Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    History of epilepsy. Significant laboratory abnormality (AST or ALT >3xULN, or GFR <60); History of aggressive behavior. Subject unwilling to abstain from ...

  10. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

    Male participants who are planning to donate sperm and do not agree not to do so for the duration of the study and through 16 weeks after last dose of ...